Stem Cell Therapy

Currently there are over 85 treatments where stem cells have been used and new medical advances are progressively adding to the list <>

These include:

  • Malignant and non-malignant blood disorders 2, 3
  • Cerebral Palsy4
  • Type 1 Diabetes4
  • Brain repair5
  • Fanconi anemia6
  • Myocardial regneration7
  • Ischemic stroke8
  • Autoimmune diseases9
  • Spinal cord injury10



References 1 2 3 4 5 6 7 8 9 10

  1. Nietfeld JJ, Pasquini MC, Logan Br, Verter F, Horowitz MM. Lifetime Probabilities of Hematopoietic Stem Cell Transplantation in the U.S. Biology of Blood and Marrow Transplantation March 2008; 14:316-322 (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2531159/)
  2. Delaney C et al. Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications. BR J Haematol. 2009 Oct; 147(2): 207-16.
  3. Broxmeyer HE. Cord blood hematopoietic stem cell transplantation. In: StemBook (Internet). Cambridge (MA): Harvard Stem Cell Institute; 2008-2010 May 26.
  4. Harris DT. Non-haematological uses of cord blood stem cells. Br J Haematol. 2009 Oct; 147(2): 177-84.
  5. Jozwiak S et al. Intracerebroventricular transplantation of cord blood-derived neural progenitors in a child with severe global brain ischemic injury. Cell Medicine, Part B of Cell Transplantation, Vol. 1, pp. 71-82, 2010.
  6. Gluckman E. Ten years of cord blood transplantation: from bench to bedside. Br J Haematol. 2009 Oct; 147(2): 192-9.
  7. Schlechta B et al. Ex-vivo expanded umbilical cord blood stem cells retain capacity for myocardial regeneration. Circ J. 2010 Jan; 74(1): 188-94. Epub 2009 Nov 19
  8. Riegelsberger UM et al. Intravenous human umbilical cord blood transplantation for stroke: impact on infarct volume and caspase-3-dependent cell death in spontaneously hypertensive rats. Exp Neurol. 2011 Jan; 227(1): 218-23. Epub 2010 Nov 16.
  9. Farge D et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica. 2010 Feb; 95(2): 284-92. Epub 2009 Sept 22.
  10. Lee JH et al. Percutaneous transplantation of human umbilical cord blood-derived multipotent stem cells in a canine model of spinal cord injury. J Neurosurg Spine. 2009 Dec; 11(6): 749-57.

A full list of current therapies and clinical trials is available on www.parentsguidecordblood.com/diseases.php